CAS 117824-04-1: 2,7-Phenanthrenediol,5-ethenyl-1,6-dimethyl-

Dehydrojuncusol is a naturally occurring phenanthrene compound, which is derived from plants of the Juncaceae family. This compound exhibits notable bioactivity due to its ability to interact with cellular targets, potentially influencing signaling pathways and exhibiting anti-inflammatory and antioxidant properties. The molecular mode of action of Dehydrojuncusol involves interaction with specific enzymes or receptors, modulating their activity and thus affecting downstream biological processes. Research into Dehydrojuncusol has highlighted its potential in therapeutic applications, particularly in addressing conditions associated with oxidative stress and inflammation. Its efficacy in experimental models suggests promising avenues for further investigation in pharmacology. Scientists are particularly interested in its role in modulating biological responses, which could lead to the development of novel therapeutics. Continued study is necessary to fully elucidate its mechanisms and optimize its applications within clinical settings.

Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is